Evidence map›Paper›PMID 35958108›Full record

ReviewResearch (Washington, D.C.)2022

Material Engineering in Gut Microbiome and Human Health.

Letao Yang, Lin Y Hung, Yuefei Zhu, Suwan Ding, Kara G Margolis, Kam W Leong

Open access · goldAbstract readReview
In one paragraph

Review in Research (Washington, D.C.), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 18 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Letao YangDepartment of Biomedical Engineering, Columbia University, New York, NY, USA.
Lin Y HungDepartment of Pediatrics, Columbia University, New York, New York, USA.
Yuefei ZhuDepartment of Biomedical Engineering, Columbia University, New York, NY, USA.
Suwan DingDepartment of Biomedical Engineering, Columbia University, New York, NY, USA.
Kara G MargolisDepartment of Pediatrics, Columbia University, New York, New York, USA.
Kam W LeongDepartment of Biomedical Engineering, Columbia University, New York, NY, USA.ORCID https://orcid.org/0000-0002-8133-4955
Columbia University · US

Funding

Engineering Polymers to Scavenge DAMPs in Arthritis and LupusR01AR073935 · NIAMS · DUKE UNIVERSITY · PI LEONG, KAM W, SULLENGER, BRUCE ALAN · 2018 to 2022
$3.3M
Focused Ultrasound-mediated Delivery of Gene-editing Elements to the Brain for Neurodegenerative DisordersUG3NS115598 · NINDS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI LEONG, KAM W · 2019 to 2021
$2.3M
NIAMS NIH HHS R01 AR073935NINDS NIH HHS UG3 NS115598
6 · The paper itself

Abstract

Tremendous progress has been made in the past decade regarding our understanding of the gut microbiome's role in human health. Currently, however, a comprehensive and focused review marrying the two distinct fields of gut microbiome and material research is lacking. To bridge the gap, the current paper discusses critical aspects of the rapidly emerging research topic of "material engineering in the gut microbiome and human health." By engaging scientists with diverse backgrounds in biomaterials, gut-microbiome axis, neuroscience, synthetic biology, tissue engineering, and biosensing in a dialogue, our goal is to accelerate the development of research tools for gut microbiome research and the development of therapeutics that target the gut microbiome. For this purpose, state-of-the-art knowledge is presented here on biomaterial technologies that facilitate the study, analysis, and manipulation of the gut microbiome, including intestinal organoids, gut-on-chip models, hydrogels for spatial mapping of gut microbiome compositions, microbiome biosensors, and oral bacteria delivery systems. In addition, a discussion is provided regarding the microbiome-gut-brain axis and the critical roles that biomaterials can play to investigate and regulate the axis. Lastly, perspectives are provided regarding future directions on how to develop and use novel biomaterials in gut microbiome research, as well as essential regulatory rules in clinical translation. In this way, we hope to inspire research into future biomaterial technologies to advance gut microbiome research and gut microbiome-based theragnostics.

Identifiers

PMID35958108
PMCPMC9343081
OpenAlexW4286499731

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.